EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review

Richard I Horowitz iD, John Fallon, Phyllis R Freeman iD

Microorganisms · 30.04.2024 · 12 (5) · 909

DOI: 10.3390/microorganisms12050909 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Microorganisms, online erschienen am 30.04.2024. Verfasst von Richard I Horowitz und 2 weiteren Autor:innen. Beteiligte Einrichtung: New York State Department of Health Tick-Borne Working Group, Albany, NY 12224, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 252 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MSIDS Research Foundation (MRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Three patients with relapsing and remitting borreliosis, babesiosis, and bartonellosis, despite extended anti-infective therapy, were prescribed double-dose dapsone combination therapy (DDDCT) for 8 weeks, followed by one or several two-week courses of pulsed high-dose dapsone combination therapy (HDDCT). We discuss these patients’ cases to illustrate three important variables required for long-term remission. First, diagnosing and treating active co-infections, including Babesia and Bartonella were important. Babesia required rotations of multiple anti-malarial drug combinations and herbal therapies, and Bartonella required one or several 6-day HDDCT pulses to achieve clinical remission. Second, all prior oral, intramuscular (IM), and/or intravenous (IV) antibiotics used for chronic Lyme disease (CLD)/post-treatment Lyme disease syndrome (PTLDS), irrespective of the length of administration, were inferior in efficacy to short-term pulsed biofilm/persister drug combination therapy i.e., dapsone, rifampin, methylene blue, and pyrazinamide, which improved resistant fatigue, pain, headaches, insomnia, and neuropsychiatric symptoms. Lastly, addressing multiple factors on the 16-point multiple systemic infectious disease syndrome (MSIDS) model was important in achieving remission. In conclusion, DDDCT with one or several 6–7-day pulses of HDDCT, while addressing abnormalities on the 16-point MSIDS map, could represent a novel effective clinical and anti-infective strategy in CLD/PTLDS and associated co-infections including Bartonella.

Schlagwörter

Stichwörter der Autor:innen

COVID-19Lyme diseasebabesiosisbartonellosisdapsone combination therapy (DDSCT)double-dose dapsone combination therapy (DDDCT)fluorescent in situ hybridization (FISH)high-dose dapsone combination therapy (HDDCT)persistent infectionpost-treatment Lyme disease syndrome (PTLDS)

Autor:innen und Institutionen

  • New York State Department of Health Tick-Borne Working Group, Albany, NY 12224, USA.
  • Hudson Valley Healing Arts Center, Hyde Park, NY 12538, USA.

ORCID-Profile: Richard I Horowitz, Phyllis R Freeman

Förderung

  • MSIDS Research Foundation (MRF)

Zitieren

APA

Horowitz, R. I., Fallon, J., & Freeman, P. R. (2024). Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review. Microorganisms, 12(5), 909. https://doi.org/10.3390/microorganisms12050909

Vancouver

Horowitz RI, Fallon J, Freeman PR. Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review. Microorganisms. 2024;12(5):909. doi:10.3390/microorganisms12050909

BibTeX
@article{Horowitz2024,
  author = {Horowitz, Richard I and Fallon, John and Freeman, Phyllis R},
  title = {Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review},
  journal = {Microorganisms},
  year = {2024},
  volume = {12},
  number = {5},
  pages = {909},
  doi = {10.3390/microorganisms12050909}
}
Kostenlos starten →